Injectable extended-release naltrexone (XR-NTX) for opioid dependence: long-term safety and effectiveness-Reference-Cited by-同舟云学术

Injectable extended-release naltrexone (XR-NTX) for opioid dependence: long-term safety and effectiveness

Published:2013-05-24 Issue:9 Volume:108 Page:1628-1637
ISSN:0965-2140
Container-title:Addiction
language:en
Short-container-title:Addiction

Author:

Krupitsky Evgeny¹,Nunes Edward V.²,Ling Walter³,Gastfriend David R.⁴,Memisoglu Asli⁴,Silverman Bernard L.⁴

Affiliation:

1. Bekhterev Research Psychoneurological Institute and St. Petersburg State Pavlov Medical University; St. Petersburg; Russian Federation

2. New York State Psychiatric Institute and Department of Psychiatry; Columbia University; New York City; NY; USA

3. Department of Psychiatry and Biobehavioral Sciences; University of California Los Angeles; Los Angeles; CA; USA

4. Alkermes, Inc.; Waltham; MA; USA

Publisher

Wiley

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/add.12208/fullpdf

Reference26 articles.

1. UNODC World Drug Report 2010 (United Nations Publication, Sales No. E.10.XI.13) 2010 http://www.unodc.org/documents/wdr/WDR_2010/World_Drug_Report_2010_lo-res.pdf http://www.webcitation.org/60NzBlRJC

2. A 24-year follow-up of California narcotics addicts;Hser;Arch Gen Psychiatry,1993

3. Association of alcohol and drug use disorders and completed suicide: an empirical review of cohort studies;Wilcox;Drug Alcohol Depend,2004

4. National Institute of Drug Abuse NIDA Research Report-Heroin Abuse and Addiction 2005

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medial prefrontal neuroplasticity during extended-release naltrexone treatment of opioid use disorder – a longitudinal structural magnetic resonance imaging study;Translational Psychiatry;2024-09-05

2. Risk of relapse to non-opioid addictive substances among opioid dependent patients treated with an opioid receptor antagonist or a partial agonist: A randomized clinical trial;Contemporary Clinical Trials;2023-12

3. Personal recovery among people with opioid use disorder during treatment with extended-release naltrexone;Heliyon;2023-07

4. Targeting Opioid Receptors in Addiction and Drug Withdrawal: Where Are We Going?;International Journal of Molecular Sciences;2023-06-29

5. Risk of acute care incidents for people treated for opioid use disorder with extended-release naltrexone and buprenorphine;Journal of Social Work Practice in the Addictions;2023-06-28